LGR5 and neoplasm: Moreover, LGR5 was recently reported to be highly upregulated in gastroenterological carcinoma [14]; the selective ablation of LGR5 + CSCs led to tumor regression, and targeting LGR5 + human colon CSCs enhanced the effects of chemotherapy [15].